Awards/COOPERATIVE AGREEMENT (B)

$429,366,468

Department of Health and Human Services·National Institutes of Health

ACTION DATE—·SOURCEUSASPENDING·SOURCE IDASST_NON_UM1AI068618_075

Award description

HVTN LABORATORY PROGRAM

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds HIV Vaccine Trials Network laboratory operations and research infrastructure for vaccine development and testing.

Sub-sectors

vaccine-developmenthiv-researchclinical-trials

Why this matters

HVTN is critical U.S. infrastructure for HIV vaccine development, a decades-long public health priority with global implications.

Supply-chain signal

Sustains demand for specialized laboratory equipment, reagents, and clinical trial support services from biotech suppliers.

U.S.–China competition angle

HIV vaccine development is a global race; U.S. leadership in this area strengthens biomedical competitiveness and soft power.

Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-13. Cost: $0.001332.

Period of performance

Start

2006-06-29

End

2024-06-30

Status

expired683 days ago

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_UM1AI068618_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.